Search Results - "Meller, Simon T"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma by George, Sally L, Falzone, Nadia, Chittenden, Sarah, Kirk, Stephanie J, Lancaster, Donna, Vaidya, Sucheta J, Mandeville, Henry, Saran, Frank, Pearson, Andrew D.J, Du, Yong, Meller, Simon T, Denis-Bacelar, Ana M, Flux, Glenn D

    Published in Nuclear medicine communications (01-05-2016)
    “…OBJECTIVEIodine-131-labelled meta-iodobenzylguanidine (I-mIBG) therapy is an established treatment modality for relapsed/refractory neuroblastoma, most…”
    Get full text
    Journal Article
  2. 2

    Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma by Buckley, Susan E, Chittenden, Sarah J, Saran, Frank H, Meller, Simon T, Flux, Glenn D

    Published in The Journal of nuclear medicine (1978) (01-09-2009)
    “…The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of…”
    Get full text
    Journal Article
  3. 3

    Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG by Flux, Glenn D, Guy, Matt J, Papavasileiou, Periklis, South, Chris, Chittenden, Sarah J, Flower, Maggie A, Meller, Simon T

    Published in Cancer biotherapy & radiopharmaceuticals (01-02-2003)
    “…Patients undergoing targeted radionuclide therapy (TRT) may receive a series of two or more treatment administrations at varying intervals. However, the level…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Whole-Body Dosimetry for Individualized Treatment Planning of ^sup 131^I-MIBG Radionuclide Therapy for Neuroblastoma by Buckley, Susan E, Chittenden, Sarah J, Saran, Frank H, Meller, Simon T, Flux, Glenn D

    Published in The Journal of nuclear medicine (1978) (01-09-2009)
    “…The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of…”
    Get full text
    Journal Article
  6. 6

    Acute leukaemia by Treleaven, Jennie, Meller, Simon T

    Published in Medicine (Abingdon. 1995, UK ed.) (01-06-2004)
    “…The acute leukaemias are divided into two main groups, reflecting their cells of origin: • acute lymphoblastic (the blast cells arise from a committed lymphoid…”
    Get full text
    Journal Article
  7. 7

    Seizures and cortical dysfunction following high-dose cisplatin administration in children by Highley, M, Meller, S T, Pinkerton, C R

    Published in Medical and pediatric oncology (1992)
    “…Four of eight children with advanced neuroblastoma treated with a rapid delivery high dose intensity cisplatin based regimen developed acute neurological…”
    Get more information
    Journal Article
  8. 8

    Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma by Gaze, Mark N, Chang, Yen-Ch'ing, Flux, Glenn D, Mairs, Rob J, Saran, Frank H, Meller, Simon T

    Published in Cancer biotherapy & radiopharmaceuticals (01-04-2005)
    “…(131)I-meta iodobenzylguanidine ((131)I-mIBG) therapy is established palliation for relapsed neuroblastoma. The topoisomerase-1 inhibitor, topotecan, has…”
    Get more information
    Journal Article
  9. 9

    High-dose rapid schedule chemotherapy for disseminated neuroblastoma by Pearson, A D, Craft, A W, Pinkerton, C R, Meller, S T, Reid, M M

    Published in European journal of cancer (1990) (1992)
    “…In a high-dose schedule for disseminated neuroblastoma, eight courses of chemotherapy were administered every 10 days, regardless of myelosuppression, to…”
    Get more information
    Journal Article
  10. 10

    Quantitative Study of Radioiodinated Metaiodobenzylguanidine Uptake in Children with Neuroblastoma: Correlation with Tumor Histopathology by Moyes, Judy S. E, Babich, John W, Carter, Richard, Meller, Simon T, Agrawal, Meena, McElwain, Timothy J

    Published in The Journal of nuclear medicine (1978) (01-04-1989)
    “…Six children with neuroblastoma and one with ganglioneuroma received [125I] metaiodobenzylguanidine (MIBG) before major surgery. Uptake of [125I]MIBG in the…”
    Get full text
    Journal Article
  11. 11

    The stability and distribution of Tc-HIDA in vivo and in vitro by Zivanovic, M A, Taylor, D M, McCready, V R, Meller, S T

    Published in European Journal of Nuclear Medicine (01-10-1979)
    “…Tc-HIDA is a promising new agent for imaging the biliary system. In this study radiochromatography on paper or Sephadex G25 gel has been used to measure the…”
    Get full text
    Journal Article
  12. 12

    High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia by Ryalls, M R, Pinkerton, C R, Meller, S T, Talbot, D, McElwain, T J

    Published in Medical and pediatric oncology (1992)
    “…Twenty children received methylprednisolone (1 g/m2), daily for 5 to 8 days, as initial single agent therapy for relapsed acute lymphoblastic leukaemia. Bone…”
    Get more information
    Journal Article